Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000921895-26-000097·STAAR SURGICAL CO
Schedule 13D ownership disclosure
STAAR SURGICAL COMPANY
Common Stock, par value $0.01 per share · CUSIP: 852312305
Event date: 2026-01-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Yunqi Path Capital Master Fund
Shares: 2,575,061.00 · Class: 5.2%
- Yunqi Capital LimitedReported CIK 0001912273
Shares: 3,257,130.00 · Class: 6.5%
- Yunqi Capital Cayman Limited
Shares: 3,257,130.00 · Class: 6.5%
- Christopher Min Fang Wang
Shares: 3,257,130.00 · Class: 6.5%
- Yunqi China Special Investment A
Shares: 682,069.00 · Class: 1.4%
- HS Group Master Fund II Ltd
Shares: 682,069.00 · Class: 1.4%
- HS Group (Hong Kong) Limited
Shares: 682,069.00 · Class: 1.4%
- HS Group Ltd
Shares: 682,069.00 · Class: 1.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-26-000097
- Form type
- SCHEDULE 13D/A
- Filer
- STAAR SURGICAL CO
- CIK
- CIK 718937
- Filed
- Jan 16, 2026
- Reporting period
- Jan 14, 2026
- Description
- Schedule 13D beneficial ownership